Market Overview

Report: Ousted Papa John's CEO Wanted To Merge With Wendy's

Share:
Report: Ousted Papa John's CEO Wanted To Merge With Wendy's

Recently ousted Papa John's Int'l, Inc. (NASDAQ: PZZA) CEO John Schnatter reportedly held merger talks with burger fast food chain Wendys Co (NASDAQ: WEN), The Wall Street Journal reported Wednesday.

What Happened

Talks between the company Schnatter founded and Wendy's were in preliminary stages, but talks between the two restaurant chains have cooled since Schnatter's departure, sources familiar with the matter told WSJ. The rationale for a merger from Wendys' point of view is unclear given the company's narrowed focus over the past few years on simplifying its operations, which resulted in 21 consecutive quarters of same-store sales gains.

Nevertheless, merger talks shouldn't come as a surprise, as Trian Fund Management, an activist hedge fund with large exposure to the food space, owns a 13-percent stake in the burger chain, WSJ said. Trian co-founder Peter May and partner Matthew Peltz sit on the Wendy's board, and Trian co-founder Nelson Peltz has been chairman since 2007.

Why It's Important

Trian has been looking to gain exposure to the pizza segment of the restaurant industry and Papa John's was considered a suitable target, Nomura's restaurant analyst Mark Kalinowski told the New York Post. The rationale behind a potential deal is that Peltz sees an opportunity for Papa John's to gain market share at the expense of "weaker competitors," Kalinowski said. 

What's Next

Papa John's' stock closed higher by 4 percent Wednesday but was trading lower by more than 1 percent premarket Thursday.

Related Links:

Wendy's 'Intriguing' 2020 Outlook Overshadowed By Valuation Concerns, Oppenheimer Says

After 44% Run, Domino's Pizza Hit With A Downgrade On Valuation

Posted-In: Fast Food hamburgers John SchnatterM&A News Restaurants Media General Best of Benzinga

 

Related Articles (PZZA + WEN)

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

10 Biggest Price Target Changes For Thursday

Benzinga's Daily Biotech Pulse: Novartis Licenses Skin Drug, 2 Stocks To Debut